A drug designed for one virus can stop others by jamming their genetic copy machines

The antiviral drug bemnifosbuvir inhibits the hepatitis E virus by targeting its RNA-dependent RNA polymerase, successfully jamming the replication machinery of a pathogen that currently lacks any approved clinical treatment.